Ariane Volkmann
9Patents
1h-index
14Co-inventors
40Inventor score
Filing activity: Mar 14, 2014 → Oct 11, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10561722B2 | Methods and compositions for enhancing immune responses | Chemistry; Metallurgy | 1 | Active |
| US11338030B2 | Multivalent recombinant modified vaccinia virus ankara (MVA) vector encoding filovirus immunogens | Emerging Cross-Sectional Technologies | 0 | Active |
| US9707291B2 | Single high dose of MVA induces a protective immune response in neonates and infants | Emerging Cross-Sectional Technologies | 0 | Active |
| US10561721B2 | Methods and compositions for inducing protective immunity against filovirus infection | Emerging Cross-Sectional Technologies | 0 | Active |
| US10925956B2 | Methods and compositions for inducing protective immunity against a marburg virus infection | Chemistry; Metallurgy | 0 | Active |
| US11173201B2 | Methods and compositions for inducing protective immunity against filovirus infection | Emerging Cross-Sectional Technologies | 0 | Active |
| US10653766B2 | Use of oil and water emulsions for increasing B cell responses with modified Vaccinia Ankara virus | Emerging Cross-Sectional Technologies | 0 | Active |
| US10576141B2 | Recombinant modified vaccinia virus Ankara (MVA) multivalent filovirus immunogenic compositions and methods of use | Emerging Cross-Sectional Technologies | 0 | Active |
| US11918639B2 | Methods and compositions for inducing protective immunity against filovirus infection | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.